Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zymeworks Inc
(NY:
ZYME
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 15, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zymeworks Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Zymeworks Announces Participation in Upcoming Investor Conferences
May 28, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm
May 19, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)
May 16, 2024
From
Kirby McInerney LLP
Via
Business Wire
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
May 07, 2024
Via
Benzinga
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 02, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
April 30, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 11, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
April 08, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm
April 03, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)
April 02, 2024
From
Kirby McInerney LLP
Via
GlobeNewswire
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
March 28, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
March 27, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
March 08, 2024
Explore top tech stocks to dominate the decade, with their fundamental leading in information technology, finance, and health care.
Via
InvestorPlace
ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023
March 06, 2024
ZYME stock results show that Zymeworks beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
March 05, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
February 27, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Earnings Scheduled For March 6, 2024
March 06, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via
Benzinga
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
February 22, 2024
Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price.
Via
InvestorPlace
Last Call! 7 Small-Cap Stocks Ready to Explode in Value
February 20, 2024
Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value.
Via
InvestorPlace
Zymeworks - Analysts Project A Big Turnaround
February 20, 2024
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.
Via
Talk Markets
7 Small-Cap Stocks With Significant Upside Potential in 2024
February 15, 2024
Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on.
Via
InvestorPlace
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
February 14, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer
February 09, 2024
Via
Investor Brand Network
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
February 08, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
3 Top Stocks to Buy This Winter for Sizzling Summer Gains
January 31, 2024
With economic momentum accelerating, these three top stocks flying under Wall Street's radar seem poised for sizzling summer gains.
Via
InvestorPlace
Zymeworks Announces Participation in Upcoming Investor Conferences
January 31, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
A Look Into Healthcare Sector Value Stocks
January 22, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
January 15, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.